126: [Bonus content] Commercial risk is possible—here's how
Radio Advisory
00:00
Emerging Opportunities in the Medacare Population
With the exception of labor and delivery, we would expect things like edy utilization to be a top opportunity in the medacare population. The issue is in commercial that a lot of the e d utilization is simply not avoidable. We've seen almost a doubling of cemo therapy cost in the commercial population in the last five years. But it's such an outlier compared to all these other sub service lines that we're seeing.
Play episode from 08:44
Transcript
